[1]Patent:JP2005/314398,2005,A.Locationinpatent:Page/Pagecolumn26
[2]Synlett,1999,p.1301-1303
[1]CurrentPatentAssignee:SHANDONGXUANZHUPHARMA;SIHUANPHARMACEUTICALHOLDINGSGROUPLTD.-EP3878854,2021,A1
245365-64-4
198572-71-3
24623-42-5 | 1,3-Dichloro-6,7-dimethoxyisoquinoline | AA002OQT | MFCD14704915
247089-85-6 | (R)-(-)-P-Toluenesulfinamide | AA002P1T | MFCD06858374
24764-66-7 | 1-(4-Methoxy-1-naphthalenyl)-ethanone | AA002PAM | MFCD00156696
2487-26-5 | 2-Nitrophenyl butyrate | AA002PN4 | MFCD00036217
2494-56-6 | Butyrylcholine iodide | AA002PUW | MFCD00038730
25067-59-8 | 9H-Carbazole, 9-ethenyl-, homopolymer | AA002QA8 | MFCD00134336
251565-85-2 | Tesaglitazar | AA002QLG | MFCD07784004
252061-78-2 | 6-Hydroxyisoquinolin-1(2h)-one | AA002QUQ | MFCD12405871
25977-19-9 | 3-Chloromethyl-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester | AA002R6I | MFCD09749852
26066-16-0 | 1-(Chloromethyl)-3-isopropoxybenzene | AA002RHJ | MFCD11121536